Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Three-Compartment Open Model01:06

Three-Compartment Open Model

421
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
421
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

319
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
319
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

140
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
140

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ characterization of aerosol deposition in dry powder inhalers using optical coherence tomography.

International journal of pharmaceutics·2026
Same author

Proteomic profiling of metabolizing enzymes and transporters in 2 layers of Caucasian human skin.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Influence of inflammation on drug transporter expression in human airway epithelia: Implications for inhaled drug pharmacokinetics.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Regional Nasal Drug Deposition in Pediatric vs. Adult Models: In vitro Insights into User Technique and Breathing Patterns Sensitivity.

Pharmaceutical research·2026
Same author

Mechanistic modeling of amyloid dynamics relating to Alzheimer's disease progression.

Frontiers in aging neuroscience·2026
Same author

Modeling lung transporters and their influence on inhaled drug disposition.

Pharmacological reviews·2025

Related Experiment Video

Updated: Sep 10, 2025

Development of an In Vitro Ocular Platform to Test Contact Lenses
08:28

Development of an In Vitro Ocular Platform to Test Contact Lenses

Published on: April 6, 2016

10.7K

Quasi-3D Mechanistic Model for Predicting Eye Drop Distribution in the Human Tear Film.

Harsha T Garimella1, Carly Norris1, Carrie German1

  • 1Biomedical, Energy, and Materials Division, CFD Research Corporation, 6820 Moquin Drive NW, Huntsville, AL 35806, USA.

Bioengineering (Basel, Switzerland)
|August 28, 2025
PubMed
Summary

A new quasi-3D (Q3D) tear film model enhances ocular drug delivery simulations by incorporating blinking and drainage. This fast-running computational model improves drug absorption predictions for conditions like glaucoma and dry eye.

Keywords:
blinkingdexamethasonedrainageeye dropfast-runningquasi-3Dtear film

More Related Videos

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
05:21

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

745
Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

3.9K

Related Experiment Videos

Last Updated: Sep 10, 2025

Development of an In Vitro Ocular Platform to Test Contact Lenses
08:28

Development of an In Vitro Ocular Platform to Test Contact Lenses

Published on: April 6, 2016

10.7K
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
05:21

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

745
Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

3.9K

Area of Science:

  • Ocular pharmacology and computational modeling.
  • Biomedical engineering and drug delivery systems.

Background:

  • Topical ocular drug administration is crucial for treating conditions like glaucoma and dry eye.
  • Physiologically based pharmacokinetic (PBPK) modeling predicts drug efficacy but often requires high-resolution, time-consuming simulations.
  • Existing models lack detailed mechanistic factors of the tear film environment.

Purpose of the Study:

  • To develop a fast-running, quasi-3D (Q3D) computational model of the human tear film.
  • To incorporate critical mechanistic factors such as blinking, drainage, absorption, and evaporation into ocular drug delivery simulations.
  • To improve the accuracy and efficiency of predicting drug distribution and absorption in the eye.

Main Methods:

  • Developed a quasi-3D (Q3D) computational model of the human tear film.
  • Integrated blinking mechanics, fluid flow, absorption, drainage, and evaporation into the model.
  • Quantified average drug absorption using a high-resolution compartment model and ordinary differential equations (ODEs).
  • Validated simulations against experimental data of topical dexamethasone suspension.

Main Results:

  • The Q3D tear film model successfully simulated blinking mechanics and flow distributions.
  • Model predictions showed good agreement with experimental data for drug absorption (R² = 0.76).
  • Achieved significant reduction in computational time (CPU time) while maintaining prediction accuracy.

Conclusions:

  • The developed Q3D tear film model provides a computationally efficient and accurate tool for simulating topical ocular drug delivery.
  • This model accounts for key physiological factors previously omitted in fast-running simulations.
  • Facilitates seamless integration into full-body PBPK models, advancing the development of ophthalmic treatments.